| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
34,000,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
18,050 |
Avg
Vol: |
18,000 |
| 52
Week Range: |
$238.6 - $238.6 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Heberlig Chris |
Vice President, Finance |
• – – |
2013-07-16 |
4 |
AS |
$48.26 |
$97,920 |
D/D |
(2,029) |
0 |
|
- |
|
| Heberlig Chris |
Vice President, Finance |
• – – |
2013-07-15 |
4 |
AS |
$49.15 |
$24,329 |
D/D |
(495) |
2,029 |
|
- |
|
| Heberlig Chris |
Vice President, Finance |
• – – |
2013-07-15 |
4 |
OE |
$0.95 |
$2,698 |
D/D |
2,524 |
2,524 |
|
- |
|
| Boess Carsten |
SVP, Chief Financial Officer |
• – – |
2013-07-11 |
4 |
AS |
$47.06 |
$622,933 |
D/D |
(13,237) |
0 |
|
- |
|
| Boess Carsten |
SVP, Chief Financial Officer |
• – – |
2013-07-11 |
4 |
OE |
$1.70 |
$22,503 |
D/D |
13,237 |
13,237 |
|
- |
|
| Goldberg Mark Alan |
SVP,Medical&Regulatory Affairs |
• – – |
2013-06-28 |
4 |
A |
$35.68 |
$9,527 |
D/D |
267 |
267 |
|
- |
|
| Williams Glen |
SVP, Technical Operations |
• – – |
2013-06-28 |
4 |
A |
$35.68 |
$4,781 |
D/D |
134 |
134 |
|
- |
|
| Quinn Anthony |
SVP, Chief Medical Officer |
• – – |
2013-06-28 |
4 |
A |
$35.68 |
$10,597 |
D/D |
297 |
15,332 |
|
- |
|
| Patel Sanj K |
President & CEO |
• • – |
2013-06-12 |
4 |
AS |
$40.48 |
$1,633,449 |
D/D |
(40,352) |
1,031 |
|
- |
|
| Patel Sanj K |
President & CEO |
• • – |
2013-06-12 |
4 |
OE |
$0.95 |
$49,383 |
D/D |
40,352 |
41,383 |
|
- |
|
| Patel Sanj K |
President & CEO |
• • – |
2013-06-11 |
4 |
AS |
$40.89 |
$1,212,307 |
D/D |
(29,648) |
1,031 |
|
- |
|
| Patel Sanj K |
President & CEO |
• • – |
2013-06-11 |
4 |
OE |
$0.95 |
$28,166 |
D/D |
29,648 |
30,679 |
|
- |
|
| Patel Sanj K |
President & CEO |
• • – |
2013-04-08 |
4 |
AS |
$49.49 |
$1,073,686 |
D/D |
(21,695) |
1,031 |
|
- |
|
| Patel Sanj K |
President & CEO |
• • – |
2013-04-08 |
4 |
OE |
$0.95 |
$20,610 |
D/D |
21,695 |
22,726 |
|
- |
|
| Patel Sanj K |
President & CEO |
• • – |
2013-04-05 |
4 |
AS |
$50.11 |
$496,590 |
D/D |
(9,910) |
1,031 |
|
- |
|
| Patel Sanj K |
President & CEO |
• • – |
2013-04-05 |
4 |
OE |
$0.95 |
$9,415 |
D/D |
9,910 |
10,941 |
|
- |
|
| Patel Sanj K |
President & CEO |
• • – |
2013-04-04 |
4 |
AS |
$50.12 |
$1,102,315 |
D/D |
(21,931) |
1,031 |
|
- |
|
| Patel Sanj K |
President & CEO |
• • – |
2013-04-04 |
4 |
OE |
$0.95 |
$20,834 |
D/D |
21,931 |
22,962 |
|
- |
|
| Patel Sanj K |
President & CEO |
• • – |
2013-04-03 |
4 |
AS |
$51.09 |
$852,227 |
D/D |
(16,464) |
1,031 |
|
- |
|
| Patel Sanj K |
President & CEO |
• • – |
2013-04-03 |
4 |
OE |
$0.95 |
$15,641 |
D/D |
16,464 |
17,495 |
|
- |
|
| Goldberg Mark Alan |
SVP,Medical&Regulatory Affairs |
• – – |
2013-04-01 |
4 |
AS |
$54.21 |
$239,831 |
D/D |
(4,416) |
0 |
|
- |
|
| Goldberg Mark Alan |
SVP,Medical&Regulatory Affairs |
• – – |
2013-04-01 |
4 |
OE |
$0.95 |
$4,195 |
D/D |
4,416 |
4,416 |
|
- |
|
| Goldberg Mark Alan |
SVP, Product Development |
• – – |
2013-03-01 |
4 |
AS |
$50.39 |
$224,217 |
D/D |
(4,417) |
0 |
|
- |
|
| Goldberg Mark Alan |
SVP, Product Development |
• – – |
2013-03-01 |
4 |
OE |
$0.95 |
$4,196 |
D/D |
4,417 |
4,417 |
|
- |
|
| Patel Sanj K |
President & CEO |
• • – |
2013-02-21 |
4 |
AS |
$49.02 |
$2,225,116 |
D/D |
(45,392) |
1,031 |
|
- |
|
372 Records found
|
|
Page 6 of 15 |
|
|
